(American Thoracic Society) Patients hospitalized with mild to moderate community-acquired pneumonia should not be routinely prescribed prednisolone, a corticosteroid, as it is associated with a recurrence of symptoms after its withdrawal, according to the first randomized double-blind clinical trial to address the subject.

Further information:

Article source

Related posts:

1. Prednisolone not benficial in most cases of community-acquired pneumonia
2. Prednisolone not beneficial in most cases of community-acquired pneumonia
3. Kidney injury linked to greater risk of death among pneumonia patients
4. Community acquired methicillin-resistant Staphylococcus aureus pneumonia leading to rhabdomyolysis: a case report
5. Progesterone for traumatic brain injury tested in phase III clinical trial